Heligmosomoides polygyrus and Trypanosoma congolense infections in mice: a laboratory model for concurrent gastrointestinal nematode and trypanosome infections.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 8152856)

Published in Parasitology on January 01, 1994

Authors

B B Fakae1, L J Harrison, C A Ross, M M Sewell

Author Affiliations

1: Centre for Tropical Veterinary Medicine, Easter Bush, Roslin, Midlothian, UK.

Articles by these authors

(truncated to the top 100)

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell (1997) 9.57

Detection of Huntington's disease decades before diagnosis: the Predict-HD study. J Neurol Neurosurg Psychiatry (2007) 5.49

Microsatellite evolution--evidence for directionality and variation in rate between species. Nat Genet (1995) 4.77

Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat Med (2001) 4.22

Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science (2001) 4.13

Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum Mol Genet (1999) 4.06

Childhood trauma, psychosis and schizophrenia: a literature review with theoretical and clinical implications. Acta Psychiatr Scand (2005) 3.96

Antigenic relationship of varicella-zoster and herpes simplex. Lancet (1965) 3.33

CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology (2012) 3.12

Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. Hum Mol Genet (2000) 3.07

Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology (2004) 2.81

Influenza, respiratory syncytial virus, and pneumonia in Glasgow, 1962-5. Br Med J (1967) 2.76

A huntingtin-associated protein enriched in brain with implications for pathology. Nature (1995) 2.67

Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. Mol Psychiatry (2007) 2.53

Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions. Nat Genet (1999) 2.53

Anticipation in bipolar affective disorder. Am J Hum Genet (1993) 2.44

Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. Hum Mol Genet (1998) 2.39

A frameshift mutation in Disrupted in Schizophrenia 1 in an American family with schizophrenia and schizoaffective disorder. Mol Psychiatry (2005) 2.32

Huntingtin-associated protein 1 (HAP1) interacts with the p150Glued subunit of dynactin. Hum Mol Genet (1997) 2.28

Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J Biol Chem (1998) 2.23

Two-year follow-up of inpatients with dissociative identity disorder. Am J Psychiatry (1997) 2.18

Basic research by medical students. J R Soc Med (1981) 2.15

Clinical markers of early disease in persons near onset of Huntington's disease. Neurology (2001) 2.11

The inositol 1,4,5,-trisphosphate receptor in cerebellar Purkinje cells: quantitative immunogold labeling reveals concentration in an ER subcompartment. J Cell Biol (1990) 2.03

Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15. Hum Mol Genet (1993) 2.00

Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length. Neurobiol Dis (1998) 1.96

Millon Clinical Multiaxial Inventory--II. Follow-up of patients with dissociative identity disorder. Psychol Rep (1996) 1.95

Wild-type huntingtin protects from apoptosis upstream of caspase-3. J Neurosci (2000) 1.92

Lymphocyte apoptosis: mediation by increased type 3 inositol 1,4,5-trisphosphate receptor. Science (1996) 1.92

Tonic vasomotor control by the rostral ventrolateral medulla: effect of electrical or chemical stimulation of the area containing C1 adrenaline neurons on arterial pressure, heart rate, and plasma catecholamines and vasopressin. J Neurosci (1984) 1.89

Endothelin: visualization of mRNAs by in situ hybridization provides evidence for local action. Proc Natl Acad Sci U S A (1989) 1.87

Validity of the Dissociative Experiences Scale in screening for multiple personality disorder: a multicenter study. Am J Psychiatry (1993) 1.87

Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization. Nat Med (1999) 1.86

Inositol 1,4,5-trisphosphate receptors: distinct neuronal and nonneuronal forms derived by alternative splicing differ in phosphorylation. Proc Natl Acad Sci U S A (1991) 1.76

Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. Hum Mol Genet (2001) 1.74

Expansion of a novel CAG trinucleotide repeat in the 5' region of PPP2R2B is associated with SCA12. Nat Genet (1999) 1.74

Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease. Mov Disord (2000) 1.67

Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease. Neurobiol Dis (2001) 1.57

A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2. Nat Genet (2001) 1.56

Longitudinal change in basal ganglia volume in patients with Huntington's disease. Neurology (1997) 1.56

Endothelin in brain: receptors, mitogenesis, and biosynthesis in glial cells. Proc Natl Acad Sci U S A (1990) 1.55

Atrophin-1, the DRPLA gene product, interacts with two families of WW domain-containing proteins. Mol Cell Neurosci (1998) 1.53

The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis. Proc Natl Acad Sci U S A (2001) 1.51

Herpes zoster in general practice. J R Coll Gen Pract (1975) 1.51

Dentatorubral and pallidoluysian atrophy (DRPLA). Clinical and neuropathological findings in genetically confirmed North American and European pedigrees. Mov Disord (1997) 1.49

Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders. Mol Psychiatry (2010) 1.49

Infective agents and embryopathy in the west of Scotland 1966-1970. Scott Med J (1972) 1.48

Rostral ventrolateral medulla: selective projections to the thoracic autonomic cell column from the region containing C1 adrenaline neurons. J Comp Neurol (1984) 1.48

The active site and mechanism of action of bovine pancreatic ribonuclease. 7. The catalytic mechanism. Biochem J (1962) 1.47

Novel triplet repeat containing genes in human brain: cloning, expression, and length polymorphisms. Genomics (1993) 1.47

Schizophrenia: a disease of heteromodal association cortex? Neuropsychopharmacology (1996) 1.47

Specific IgM antibody in serum of patients with herpes zoster infections. Br Med J (1972) 1.45

The Valsalva DCR bubble test: a new method of assessing lacrimal patency after DCR surgery. Ophthal Plast Reconstr Surg (1994) 1.44

Detection of a large CTG/CAG trinucleotide repeat expansion in a Danish schizophrenia kindred. Am J Med Genet (1997) 1.42

A specific antigen-detection ELISA for the diagnosis of human neurocysticercosis. The Cysticercosis Working Group in Peru. Trans R Soc Trop Med Hyg (1998) 1.41

Herpes simplex and temporal lobe epilepsy. Br Med J (1972) 1.40

Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation. Mol Psychiatry (2011) 1.39

Nuclear targeting of mutant Huntingtin increases toxicity. Mol Cell Neurosci (1999) 1.39

The prevalence and biometric structure of pathological dissociation in the general population: taxometric and behavior genetic findings. J Abnorm Psychol (1997) 1.39

Two horses with hypocalcaemia. Vet Rec (1991) 1.38

Frontal lobe volume in patients with Huntington's disease. Neurology (1998) 1.38

Differential cellular expression of isoforms of inositol 1,4,5-triphosphate receptors in neurons and glia in brain. J Comp Neurol (1999) 1.37

Encephalitis. A four-year survey. Lancet (1968) 1.37

Infective agents and chronic bronchitis. Thorax (1966) 1.36

Synphilin-1 is present in Lewy bodies in Parkinson's disease. Ann Neurol (2000) 1.36

FKBP12 binds the inositol 1,4,5-trisphosphate receptor at leucine-proline (1400-1401) and anchors calcineurin to this FK506-like domain. J Biol Chem (1997) 1.32

Differential diagnosis of Taenia saginata and Taenia solium infection by PCR. J Clin Microbiol (2000) 1.31

The association of CAG repeat length with clinical progression in Huntington disease. Neurology (2006) 1.29

cDNAs with long CAG trinucleotide repeats from human brain. Hum Genet (1997) 1.28

Coenzyme Q10 and remacemide hydrochloride ameliorate motor deficits in a Huntington's disease transgenic mouse model. Neurosci Lett (2001) 1.26

Myocarditis associated with psittacosis. Br J Clin Pract (1971) 1.25

Age- and race-specific reference ranges for prostate-specific antigen from a large community-based study. Urology (1996) 1.24

Active immunization alters the plasma nicotine concentration in rats. J Pharmacol Exp Ther (1997) 1.23

Human neurocysticercosis: comparison of enzyme immunoassay capture techniques based on monoclonal and polyclonal antibodies for the detection of parasite products in cerebrospinal fluid. Trans R Soc Trop Med Hyg (1990) 1.22

Type 3 inositol 1,4,5-trisphosphate receptor modulates cell death. FASEB J (2000) 1.22

Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease. Neurosci Lett (1991) 1.21

Huntingtin-associated protein 1 (HAP1) binds to a Trio-like polypeptide, with a rac1 guanine nucleotide exchange factor domain. Hum Mol Genet (1997) 1.21

SCA-12: Tremor with cerebellar and cortical atrophy is associated with a CAG repeat expansion. Neurology (2001) 1.20

SCA12 is a rare locus for autosomal dominant cerebellar ataxia: a study of an Indian family. Ann Neurol (2001) 1.20

Familial influence on age of onset among siblings with Huntington disease. Am J Med Genet (2001) 1.20

In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder. Arch Gen Psychiatry (1995) 1.20

Childhood physical and sexual abuse in patients with anxiety disorders and in a community sample. Am J Psychiatry (1996) 1.17

Serum antigen detection in the diagnosis, treatment, and follow-up of neurocysticercosis patients. Trans R Soc Trop Med Hyg (2001) 1.17

Anchored reference loci in loblolly pine (Pinus taeda L.) for integrating pine genomics. Genetics (2001) 1.16

The neuropathology of aminergic nuclei in Alzheimer's disease. Ann Neurol (1988) 1.16

Projections from the nucleus tractus solitarii to the rostral ventrolateral medulla. J Comp Neurol (1985) 1.15

Orientation-controlled self-assembled nanolithography using a polystyrene-polydimethylsiloxane block copolymer. Nano Lett (2007) 1.15

Expression of the Huntington's disease (IT15) protein product in HD patients. Hum Mol Genet (1995) 1.15

Atrophin-1, the dentato-rubral and pallido-luysian atrophy gene product, interacts with ETO/MTG8 in the nuclear matrix and represses transcription. J Cell Biol (2000) 1.14

Nanowire conductive polymer gas sensor patterned using self-assembled block copolymer lithography. Nano Lett (2008) 1.14

Isolation of a 40-kDa Huntingtin-associated protein. J Biol Chem (2000) 1.13

Trinucleotide repeat length and clinical progression in Huntington's disease. Neurology (1996) 1.12

A comparative virological study of children in hospital with respiratory and diarrhoeal illnesses. J Hyg (Lond) (1967) 1.12

Localization of inositol trisphosphate receptor subtype 3 to insulin and somatostatin secretory granules and regulation of expression in islets and insulinoma cells. Proc Natl Acad Sci U S A (1994) 1.11

New approaches in the diagnosis of Taenia solium cysticercosis and taeniasis. Ann Parasitol Hum Comp (1990) 1.10

Complex self-assembled patterns using sparse commensurate templates with locally varying motifs. Nat Nanotechnol (2010) 1.10

Patterns of dissociation in clinical and nonclinical samples. J Nerv Ment Dis (1996) 1.09

The role of deprivation, abuse, and trauma in pediatric catatonia without a clear medical cause. Acta Psychiatr Scand (2011) 1.09

Ethyl-EPA in Huntington disease: a double-blind, randomized, placebo-controlled trial. Neurology (2005) 1.09

Limitations of current diagnostic procedures for the diagnosis of Taenia solium cysticercosis in rural pigs. Vet Parasitol (1998) 1.08